Bicycle Therapeutics: Trading At Cash, Underwhelming But Not Unsalvageable Data
Bicycle Therapeutics' BT8009 offers strong safety and efficacy. Find out why BCYC stock could be a buy, despite recent volatility and awaiting mid-2025 data.
Targeted Oncology2d
FDA Expands PATHWAY HER2 (4B5) Test to Include HER2-Ultralow Status
The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...
GBS outbreak: WHO team in Pune to train health workers as city sees slowdown in cases
Guillain-Barré Syndrome (GBS) cases in Pune rose to 163 on February 3 after the health department recorded five new cases.
Pune records rise in GBS cases, 18 on ventilator support
Out of 140 patients in the city, 18 are on ventilators, but according to the experts, this is not the worst GBS outbreak in ...
Frontiers5d
Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy
Motor and sensory nerve conduction velocities and compound muscle ... Patient 2 had signs of cardiac autonomic neuropathy (tachycardia), Patient 3 had sympathetic dysfunction, and Patient 4 had ...
Neurological conditions that mimic Guillain-Barré Syndrome and how to differentiate them
GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...
Pharmaceutical Technology on MSN1d
USPTO grants patent to Vistagen’s neuropathic pain treatment
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
The Scientist3d
“Man on Fire” Syndrome, Ion Channels, and the Quest for Safer Pain Treatments
In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...
BMJ5d
Gluten sensitivity as a neurological illness
Department of Neurology, The Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK Correspondence to: Dr M Hadjivassiliou, Department of Neurology, The ...